The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin
Abstract
Aims: Cytokeratin (CK) 7 and CK19 expression, present in hepatic progenitor cells (HPCs) and in cholangiocytes but not in normal hepatocytes, has been reported in some hepatocellular carcinomas (HCCs); however, the incidence and relevance of this expression in HCC in Caucasians is not known. Therefore, our aim was to study the occurrence and clinicopathological characteristics of HCC expressing CK7 and/or CK19 in 109 Caucasian patients. Methods and results: The expression of hepatocellular differentiation markers (Hepar, canalicular polyclonal carcinoembryonic antigen), biliary/progenitor cell markers (CK7, CK19), α‐fetoprotein (AFP), p53 and β‐catenin in HCC was semiquantitatively assessed by immunohistochemistry. Of 109 HCCs, 78 were CK7–/CK19– (72%), 13 CK7+/CK19– (12%), seven CK7–/CK19+ (6%), 11 CK7+/CK19+ (10%). CK19 expression was significantly associated with elevated serum AFP (400 ng/ml) (P = 0.023), tumour AFP expression (P < 0.0001), presence in serum of anti‐hepatitis B core (P = 0.016), less fibrosis in non‐neoplastic parenchyma (P = 0.009) and less nuclear β‐catenin expression (P = 0.021). CK7 expression was significantly associated with elevated serum bilirubin (> 2 mg/dl) (P = 0.0005) and less nuclear β‐catenin expression (P = 0.003). HCC expressing CK19 had a higher rate of recurrence (P = 0.009, hazard ratio 12.5, n = 31) after liver transplantation compared with CK19– tumours. Conclusions: In our series, 28% of HCCs contained cells expressing CK7 and/or CK19. They potentially derive from HPCs. The higher recurrence rate of CK19+ HCC after transplantation suggests a worse prognosis for these HCCs compared with CK19– HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
Moll, R., Franke, W. W., Schiller, D. L., Geiger, B., & Krepler, R. (1982) · Cell · doi:10.1016/0092-8674(82)90400-7 · Cited by 5,247
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Edmondson, H. A., & Steiner, P. E. (1954) · Cancer · doi:10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e · Cited by 2,772
Bedossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,003
Roskams, T. A., Theise, N. D., Balabaud, C., Bhagat, G., Bhathal, P. S., Bioulac-Sage, P., Brunt, E. M., Crawford, J. M., Crosby, H. A., Desmet, V., et al. (2004) · Hepatology · doi:10.1002/hep.20130 · Cited by 735
Self-citationThe canals of hering and hepatic stem cells in humans
Theise, N. D., Saxena, R., Portmann, B. C., Thung, S. N., Yee, H., Chiriboga, L., Kumar, A., & Crawford, J. M. (1999) · Hepatology · doi:10.1002/hep.510300614 · Cited by 702
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Roskams, T., Yang, S. Q., Koteish, A., Durnez, A., DeVos, R., Huang, X., Achten, R., Verslype, C., & Diehl, A. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63489-x · Cited by 447
Self-citationCombined liver cell and bile duct carcinoma.
Allen, R. A., & Lisa, J. (1949) · PubMed · Cited by 423
Heterogeneity and plasticity of hepatocyte lineage cells
Sell, S. (2001) · Hepatology · doi:10.1053/jhep.2001.21900 · Cited by 396
Combined hepatocellular and cholangiocarcinoma: Demographic, clinical, and prognostic factors
Jarnagin, W. R., Weber, S., Tickoo, S. K., Koea, J. B., Obiekwe, S., Fong, Y., DeMatteo, R. P., Blumgart, L. H., & Klimstra, D. (2002) · Cancer · doi:10.1002/cncr.10392 · Cited by 342
Progenitor Cells in Diseased Human Liver
(2003) · Seminars in Liver Disease · doi:10.1055/s-2004-815564 · Cited by 336
Tangkijvanich, P., Anukulkarnkusol, N., Suwangool, P., Lertmaharit, S., Hanvivatvong, O., Kullavanijaya, P., & Poovorawan, Y. (2000) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200012000-00007 · Cited by 298
Nhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., & Buendia, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65168-1 · Cited by 295
Peng, S., Chen, W. J., Lai, P., Jeng, Y., Sheu, J., & Hsu, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20279 · Cited by 295
Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.
Sell, S., & Dunsford, H. A. (1989) · Europe PMC (PubMed Central) · Cited by 290
Lau, S. K., Prakash, S., Geller, S. A., & Alsabeh, R. (2002) · Human Pathology · doi:10.1053/hupa.2002.130104 · Cited by 288
Roskams, T., De Vos, R., Van Eyken, P., Myazaki, H., Van Damme, B., & Desmet, V. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80065-2 · Cited by 287
Self-citationCholangiocarcinoma: Current Concepts and Insights
Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50200 · Cited by 272
Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence
Uenishi, T., Kubo, S., Yamamoto, T., Shuto, T., Ogawa, M., Tanaka, H., Tanaka, S., Kaneda, K., & Hirohashi, K. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01366.x · Cited by 269
Primary liver carcinoma of intermediate (hepatocyte–cholangiocyte) phenotype
Kim, H., Park, C., Han, K.-H., Choi, J., Kim, Y. B., Kim, J. K., & Park, Y. N. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.10.023 · Cited by 212
Hepatic ‘stem cell’ malignancies in adults: four cases
Theise, N. D., Yao, J. L., Harada, K., Hytiroglou, P., Portmann, B., Thung, S. N., Tsui, W., Ohta, H., & Nakanuma, Y. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01707.x · Cited by 207
Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?
Sell, S. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101s515 · Cited by 201
Occurrence of Oval–Type Cells in Hepatitis B Virus—Associated Human Hepatocarcinogenesis
Hsia, C. C., Evarts, R. P., Nakatsukasa, H., Marsden, E. R., & Thorgeirsson, S. S. (1992) · Hepatology · doi:10.1002/hep.1840160604 · Cited by 193
From Proteomic Analysis to Clinical Significance
Ding, S.-J., Li, Y., Tan, Y.-X., Jiang, M.-R., Tian, B., Liu, Y.-K., Shao, X.-X., Ye, S.-L., Wu, J.-R., Zeng, R., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300094-mcp200 · Cited by 182
MAEDA, T., ADACHI, E., KAJIYAMA, K., SUGIMACHI, K., & TSUNEYOSHI, M. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90084-5 · Cited by 174
Histological Typing of Tumours of the Liver
Ishak, K. G., Anthony, P. P., & Sobin, L. H. (1994) · Springer eBooks · doi:10.1007/978-3-642-85156-8 · Cited by 172
Libbrecht, L., Desmet, V., Damme, B. V., & Roskams, T. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80162-2 · Cited by 165
Self-citationEyken, P. V., Sciot, R., Damme, B. V., Wolf‐Peeters, C. D., & Desmet, V. J. (1987) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00750732 · Cited by 153
Self-citationClinical and molecular analysis of combined hepatocellular-cholangiocarcinomas
Cazals-Hatem, D. L., Rebouissou, S., Bioulac‐Sage, P., Bluteau, O., Blanché, H., Franco, D., Monges, G. M., Belghiti, J., Cunha, A. S., Laurent‐Puig, P., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.04.030 · Cited by 135
Hepatic Progenitor Cells in Hepatocellular Adenomas
Libbrecht, L. J., Vos, R. D., Cassiman, D. M., Desmet, V. J., Aerts, R., & Roskams, T. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200111000-00006 · Cited by 126
Self-citationVos, R. D., & Desmet, V. J. (1992) · PubMed Central · Cited by 121
Self-citationSantoni‐Rugiu, E., Nagy, P., Jensen, M. R., Factor, V. M., & Thorgeirsson, S. S. (1996) · Europe PMC (PubMed Central) · Cited by 120
Altered Expression of β-Catenin without Genetic Mutation in Intrahepatic Cholangiocarcinoma
Sugimachi, K., Taguchi, K., Aishima, S., Tanaka, S., Shimada, M., Kajiyama, K., Sugimachi, K., & Tsuneyoshi, M. (2001) · Modern Pathology · doi:10.1038/modpathol.3880409 · Cited by 114
Braun, L., Mikumo, R., & Fausto, N. (1989) · PubMed · Cited by 102
β‐Catenin Accumulation and Mutation of Exon 3 of the β‐Catenin Gene in Hepatocellular Carcinoma
Kondo, Y., Kanai, Y., Sakamoto, M., Genda, T., Mizokami, M., Ueda, R., & Hirohashi, S. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00712.x · Cited by 102
Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus
Roskams, T. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00333-7 · Cited by 94
Self-citationExpression of cytokeratins in normal and diseased livers and in primary liver carcinomas.
Lai, Y.-S., Thung, S. N., Gerber, M. A., Chen, M., & Schaffner, F. (1989) · PubMed · Cited by 86
Robrechts, C., Vos, R. D., den Heuvel, M. V., Cutsem, E. V., Damme, B. V., Desmet, V. J., & Roskams, T. (1998) · Liver International · doi:10.1111/j.1600-0676.1998.tb00168.x · Cited by 82
Self-citationBisgaard, H. C., Parmelee, D. C., Dunsford, H. A., Sechi, S., & Thorgeirsson, S. S. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940070110 · Cited by 68
Hixson, D. C., Brown, J., McBride, A. C., & Affigne, S. (2000) · Experimental and Molecular Pathology · doi:10.1006/exmp.2000.2302 · Cited by 66
Xiao, J., Ruck, P., ADAM, A., Wang, T., & KAISERLING, E. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01544.x · Cited by 64
Yabushita, K., Yamamoto, K., Ibuki, N., Okano, N., Matsumura, S., Okamoto, R., Shimada, N., & Tsuji, T. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.210108.x · Cited by 45
Dobashi, N., Fujita, J., Murota, M., Ohtsuki, Y., Bandoh, S., Ueda, Y., Dohmoto, K., Hojo, S., Nishioka, M., Ishida, T., et al. (2000) · Cell Structure and Function · doi:10.1247/csf.25.171 · Cited by 7
Expected developments in hepatology
Forns, X., Tapias, J. M. S., Parés, A. R., Llovet, J. M., Bruix, J., & Rodés, J. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0341 · Cited by 5
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“Immunostaining for GPC3, HSP70, and glutamine synthetase and/or gene expression (GPC3, LYVE1 and survivin) are recommended to differentiate high grade dysplastic nodules from early HCC (evidence 2D; recommendation 2B) Additional staining can be considered to detect progenitor cell features (K19 and EpCAM) or assess ne…”
BackgroundInfluentialEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Self-citationGuidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Khan, S. A., Davidson, B. R., Goldin, R. D., Heaton, N., Karani, J., Pereira, S. P., Rosenberg, W. M. C., Tait, P., Taylor-Robinson, S. D., Thillainayagam, A. V., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301748 · Cited by 797
Metadata
- Authors
- Durnez, A., Verslype, C., Nevens, F., Fevery, J., Aerts, R., Pirenne, J., Lesaffre, E., Libbrecht, L., Desmet, V, & Roskams, T.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2006-07-17
- Volume
- 49
- Issue
- 2
- Pages
- 138-151
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2049988916
- Cited by
- 426
- References
- 47
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.